Literature DB >> 553328

Salicylate treatment of epidemic Kawasaki disease in New York City.

J C Jacobs.   

Abstract

Kawasaki disease, mucocutaneous lymph node syndrome, thought to be rare in the continental United States, occurred in epidemic form in New York City and adjacent New York and New Jersey in November-December, 1977. Aspirin and corticosteroids, reported to be ineffective treatment, were found to completely control the illness in affected children, provided adequate doses to achieve therapeutic blood levels were administered. Patients were found to malabsorb aspirin (and perhaps also to destroy it) and so required extraordinarily high doses during the acute phase; during recovery, doses had to be lowered to the usual range to avoid toxicity. The need for hospitalization and morbidity were reduced and, hopefully, mortality will also be reduced. The importance of not judging a drug ineffective in a disease without demonstrating adequate serum levels was again shown.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 553328     DOI: 10.1097/00007691-197901000-00013

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  3 in total

1.  Dermatology-epitomes of progress: high doses of aspirin in the treatment of mucocutaneous lymph node syndrome.

Authors:  A H Jacobs
Journal:  West J Med       Date:  1981-01

2.  Salicylate treatment in Kawasaki disease: high dose or low dose?

Authors:  T Akagi; H Kato; O Inoue; N Sato
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

3.  Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease.

Authors:  Karl Migally; Elizabeth A Braunlin; Lei Zhang; Bryce A Binstadt
Journal:  Pediatr Res       Date:  2018-05-02       Impact factor: 3.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.